1e
19
1
49
2
2
18
1b
1d
18
41
50
1d
2 29
1d
25
Jane Elizabeth Minturn, M.D., Ph.D.
88
50
Clinical Professor of Pediatrics (Oncology)
28
95
3
61
Assistant Physician in Oncology, Division of Oncology, The Children's Hospital of Philadelphia
a0
Full Member-Pediatric Oncology Research Program, Abramson Cancer Center of the University of Pennsylvania
8a
Cancer Center Liaison, Global Patient Services, Children's Hospital of Philadelphia
90
Director of Clinical Operations, Neuro-Oncology Section, Children’s Hospital of Philadelphia
7
11
Department: Pediatrics
4
1
b
1d
46
Contact information
51
4
3
3
1d
51
Children's Hospital of Philadelphia
26 Division of Oncology, HUB 3590
3e 3500 Civic Center Boulevard
Philadelphia, PA 19104
26
26 Division of Oncology, HUB 3590
3e 3500 Civic Center Boulevard
Philadelphia, PA 19104
2e
Office: 267-426-5026
32 Fax: 215-590-3296
24
f
32 Fax: 215-590-3296
24
18
Publications
23 a
3
2
29
4
b
1f
23 a
13
Education:
21 9 B.S. 1a (Psychobiology) c
3a University of Southern California, 1986.
21 c M.Phil. 17 (Philosophy) c
28 Yale University, 1993.
21 9 M.D. 15 (Medicine) c
3b Yale University School of Medicine, 1996.
21 a Ph.D. 19 (Neurobiology) c
28 Yale University, 1996.
c
3
3
3
3
8b
Permanent link21 9 B.S. 1a (Psychobiology) c
3a University of Southern California, 1986.
21 c M.Phil. 17 (Philosophy) c
28 Yale University, 1993.
21 9 M.D. 15 (Medicine) c
3b Yale University School of Medicine, 1996.
21 a Ph.D. 19 (Neurobiology) c
28 Yale University, 1996.
c
2 29
21
1e
1d
24
5e
62 Understanding neuro-cognitive late effects in children treated for brain tumors in infancy
5c Understanding caregiver challenges of young adult survivors of childhood brain tumors
65
3a Late Effects in Survivors of Pediatric Brain Tumors
62
e 29
27
Description of Research Expertise
65 Early phase clinical trial development in pediatric central nervous system tumors.62 Understanding neuro-cognitive late effects in children treated for brain tumors in infancy
5c Understanding caregiver challenges of young adult survivors of childhood brain tumors
65
Description of Clinical Expertise
4a Developmental Therapeutics in Pediatric Brain Tumors.3a Late Effects in Survivors of Pediatric Brain Tumors
62
Description of Other Expertise
8d Division of Oncology Clinical Liaison, Department of Global Patient Services Program, The Children's Hospital of Philadelphiae 29
23
156 Barakat LP, Hammer SN, Knafl GJ, Stevens E, Hobbie WL, Minturn JE, Knafl KA, Deatrick JA: Acceptability and feasibility of a problem-solving intervention for maternal caregivers of young adult survivors of childhood brain tumors. Psychooncology 35(2): e70288, Feb 2026.
1b3 Wong D, Lin F, Kline C, Wu J, Schubert J, Chen J, Golenberg N, Naveh N, Patel M, Xu F, Cao K, fu W, Denenberg E, Fanning EZ, Gallo D, Zelley K, Belasco J, Desai K, Foster JB, Kotch C, Minturn J, Shah A, Lang SS, Madsen PJ, Hill-Kayser CE, LaRiviere M, Li Y, Wertheim G, Luo M, Surrey LF, Zhong Y, Viaene AN, Brodeur GM, MacFarland SP, Santi M, Resnick A, Storm PB, Fisher MJ, Cole KA, Li MM. bb : Integrated molecular and clinical analysis of over 500 pediatric central nervous system tumors. Neuro-Oncology Pediatrics "Accepted for publication" 2026.
268 Yu B, Kline C, Hoare O, Jung J, Knowles T, Ranavaya A, Minturn J, Banerjee A, Leary S, Crotty E, Abdelbaki M, Whipple N, Goldman S, Margol, A, Bhatia A, Dababo N, George E, Nabavizadeh A, Pampaloni MH, Inagaki A, Collins S, Chuntova P, Barcova M, Patel TS, Phillips J, Prados M, Molinaro A, Gupta N, Raffel C, Cole K, Kasahara N, Diaz AA, Mueller S: Measles oncolytic virus as an immunotherapy for recurrent/refractory pediatric medulloblastoma and atypical teratoid rhabdoid tumor: results from PNO005. Clin Cancer Res 31(16): 3463, Aug 2025.
12b Hammer SN, Deatrick JA, Knafl KA, Knafl GJ, Hobbie WL, Stevens E, Minturn JE, Barakat LP: Evaluating a Self- and Family Management Framework for Young Adult Survivors of Childhood Brain Tumors. J Fam Nurs 31(2): 140, May 2025.
109 Hocking MC, Schultz RT, Fantozzi P, Herrington JD, Yerys BE, Minuturn JE: White matter connectivity and social functioning in survivors of pediatric brain tumor. J Neurooncol 169(2), Sep 2024.
1be Haas-Kogan DA, Aboian MS, Minturn JE, Leary SES, Abdelbaki MS, Goldman S, Elster JD, Kraya A, Lueder MR, Ramakrishnan D, von Reppert M, Liu KX, Rokita JL, Resnick AC, Solomon DA, Phillips JJ, Prados M, Molinaro AM, Waszak SM, Mueller S: Everolimus for Children with Recurrent or Progressive Low-Grade Glioma: Results from the Phase II PNOC001 Trial. J Clin Oncol Feb 2024.
21a Das A, Tabori U, Sambira Nahum LC, Collins NB, Deyell R, Dvir R, Faure-Conter C, Hassall TE, Minturn JE, Edwards M, Brookes E, Bianchi V, Levine A, Stone SC, Sudhaman S, Sanchez-Ramirez S, Ercan AB, Stengs L, Chung J, Negm L, Getz G, Maruvka YE, Ertl-Wagner B, Ohashi PS, Pugh T, Hawkins C, Bouffet E, Morgenstern DA. : Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency. Clin Cancer Res 29(23): 4770, December 2023.
152 Kotch C, Elgarten C, Wilhelm D, Schmus, McWhorter J, Li Y, Minturn JE: The impact of proactive gastrostomy tube placement on treatment-related outcomes in young children with high-grade central nervous system tumors. J Pediatr Hematol Oncol 45(6): 333, August 2023.
120 Gubbiotti MA, Madsen P, Abdullaev Z, Aldape K, Shekdar K, Yang A, Minturn JE, Santi M, Viaene AN: ZFTA-fused supratentorial ependymoma with novel fusion partner, DUX4. J Neuropathol Exp Neurol 82(7): 668, June 2023.
2c
7
1d
1f
Selected Publications
1b8 Song JH, Baron J, Perez CC, Ramesh S, Minturn J, Desai KA, Shah AC, Belasco J, Cole KA, Fisher MJ, Storm PB, Madsen PM, Kurtz G, Lustig RA, Hill-Kayser C, LaRiviere MJ: Feasibility and safety of high-dose proton re-irradiation in recurrent pediatric central nervous system tumors: a single-institution retrospective study. Pediatric Blood Cancer 4: e70371, May 2026.156 Barakat LP, Hammer SN, Knafl GJ, Stevens E, Hobbie WL, Minturn JE, Knafl KA, Deatrick JA: Acceptability and feasibility of a problem-solving intervention for maternal caregivers of young adult survivors of childhood brain tumors. Psychooncology 35(2): e70288, Feb 2026.
1b3 Wong D, Lin F, Kline C, Wu J, Schubert J, Chen J, Golenberg N, Naveh N, Patel M, Xu F, Cao K, fu W, Denenberg E, Fanning EZ, Gallo D, Zelley K, Belasco J, Desai K, Foster JB, Kotch C, Minturn J, Shah A, Lang SS, Madsen PJ, Hill-Kayser CE, LaRiviere M, Li Y, Wertheim G, Luo M, Surrey LF, Zhong Y, Viaene AN, Brodeur GM, MacFarland SP, Santi M, Resnick A, Storm PB, Fisher MJ, Cole KA, Li MM. bb : Integrated molecular and clinical analysis of over 500 pediatric central nervous system tumors. Neuro-Oncology Pediatrics "Accepted for publication" 2026.
268 Yu B, Kline C, Hoare O, Jung J, Knowles T, Ranavaya A, Minturn J, Banerjee A, Leary S, Crotty E, Abdelbaki M, Whipple N, Goldman S, Margol, A, Bhatia A, Dababo N, George E, Nabavizadeh A, Pampaloni MH, Inagaki A, Collins S, Chuntova P, Barcova M, Patel TS, Phillips J, Prados M, Molinaro A, Gupta N, Raffel C, Cole K, Kasahara N, Diaz AA, Mueller S: Measles oncolytic virus as an immunotherapy for recurrent/refractory pediatric medulloblastoma and atypical teratoid rhabdoid tumor: results from PNO005. Clin Cancer Res 31(16): 3463, Aug 2025.
12b Hammer SN, Deatrick JA, Knafl KA, Knafl GJ, Hobbie WL, Stevens E, Minturn JE, Barakat LP: Evaluating a Self- and Family Management Framework for Young Adult Survivors of Childhood Brain Tumors. J Fam Nurs 31(2): 140, May 2025.
109 Hocking MC, Schultz RT, Fantozzi P, Herrington JD, Yerys BE, Minuturn JE: White matter connectivity and social functioning in survivors of pediatric brain tumor. J Neurooncol 169(2), Sep 2024.
1be Haas-Kogan DA, Aboian MS, Minturn JE, Leary SES, Abdelbaki MS, Goldman S, Elster JD, Kraya A, Lueder MR, Ramakrishnan D, von Reppert M, Liu KX, Rokita JL, Resnick AC, Solomon DA, Phillips JJ, Prados M, Molinaro AM, Waszak SM, Mueller S: Everolimus for Children with Recurrent or Progressive Low-Grade Glioma: Results from the Phase II PNOC001 Trial. J Clin Oncol Feb 2024.
21a Das A, Tabori U, Sambira Nahum LC, Collins NB, Deyell R, Dvir R, Faure-Conter C, Hassall TE, Minturn JE, Edwards M, Brookes E, Bianchi V, Levine A, Stone SC, Sudhaman S, Sanchez-Ramirez S, Ercan AB, Stengs L, Chung J, Negm L, Getz G, Maruvka YE, Ertl-Wagner B, Ohashi PS, Pugh T, Hawkins C, Bouffet E, Morgenstern DA. : Efficacy of nivolumab in pediatric cancers with high mutation burden and mismatch-repair deficiency. Clin Cancer Res 29(23): 4770, December 2023.
152 Kotch C, Elgarten C, Wilhelm D, Schmus, McWhorter J, Li Y, Minturn JE: The impact of proactive gastrostomy tube placement on treatment-related outcomes in young children with high-grade central nervous system tumors. J Pediatr Hematol Oncol 45(6): 333, August 2023.
120 Gubbiotti MA, Madsen P, Abdullaev Z, Aldape K, Shekdar K, Yang A, Minturn JE, Santi M, Viaene AN: ZFTA-fused supratentorial ependymoma with novel fusion partner, DUX4. J Neuropathol Exp Neurol 82(7): 668, June 2023.
2c